What is Johnson & Johnson's eduran trilpivirine — percent change (as a percent)?

Johnson & Johnson (JNJ) reported eduran trilpivirine — percent change (as a percent) of 25.4% in Q3 2025.

What does eduran trilpivirine — percent change (as a percent) mean?

The percentage growth or decline in sales for the drug EDURANT compared to the previous period.

EDURAN Trilpivirine — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson EDURAN Trilpivirine — Percent Change (as a percent) increased by 32.3% to 25.4% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 217.5%, from 8.0% to 25.4%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

Positive growth rates suggest strong market penetration or successful lifecycle management, whereas negative rates indicate potential market saturation or loss of market share to newer therapies.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the EDURANT (rilpivirine) prod...

Peer comparison

Comparable to year-over-year or quarter-over-quarter revenue growth percentages reported for specific blockbuster drugs or key therapeutic assets by peer pharmaceutical firms.

Metric ID: jnj_segment_edurant_rilpivirine_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	6.1%	-4.2%	27.7%	-8.3%	-30.7%	-36.5%	24.8%	52.6%	21.4%	19.7%	8%	20.4%	19.2%	25.4%
QoQ Change	—	-168.9%	+759.5%	-130.0%	-269.9%	-18.9%	+167.9%	+112.1%	-59.3%	-7.9%	-59.4%	+155.0%	-5.9%	+32.3%
YoY Change	—	—	—	-236.1%	-631.0%	-231.8%	+398.8%	+271.3%	—	-20.6%	-84.8%	-4.7%	-2.5%	+217.5%

Range-36.5% – 52.6%

CAGR+55.1%

Avg YoY Growth-32.4%

Median YoY Growth-12.6%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's eduran trilpivirine — percent change (as a percent)?: Johnson & Johnson (JNJ) reported eduran trilpivirine — percent change (as a percent) of 25.4% in Q3 2025.
How has Johnson & Johnson's eduran trilpivirine — percent change (as a percent) changed year-over-year?: Johnson & Johnson's eduran trilpivirine — percent change (as a percent) increased by 217.5% year-over-year, from 8.0% to 25.4%.
What does eduran trilpivirine — percent change (as a percent) mean?: The percentage growth or decline in sales for the drug EDURANT compared to the previous period.